Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Healthcare-Focused Broadfin Capital’s Notable Moves Include Cardiovascular Systems, Nevro Corp & Others

#2 Nevro Corp (NYSE:NVRO)

– Shares Owned by Broadfin Capital (as of March 31): 667,900

– Value of Holding (as of March 31): $37.58 Million

On the other hand, Broadfin significantly cut its stake in Nevro Corp (NYSE:NVRO), by 44%, but also initiated a ‘Call’ position in the $2 billion medical device company underlying 300,000 shares. In its financial results for the first quarter the Redwood-based company delivered a loss of $0.33 per share, which bested estimates by $0.32. Quarterly revenue of $41.7 million was also ahead of expectations by $6.97 million.  With some 895,000 shares of Nevro Corp (NYSE:NVRO) valued at $50.35 million as of the end of March, Clifford Fox’s Columbus Circle Investors is the largest stockholder of the company within our database.

Follow Nevro Corp (NYSE:NVRO)
Trade (NYSE:NVRO) Now!

#1 Novadaq Technologies Inc. (NASDAQ:NVDQ)

– Shares Owned by Broadfin Capital (as of March 31): 5.47 Million

– Value of Holding (as of March 31): $60.61 Million

Following a hike of 48%, Broadfin’s Novadaq Technologies Inc. (NASDAQ:NVDQ) holding accounted for over 9.7% of the medical imaging systems company’s outstanding stock. So far this year, Novadaq’s shares have suffered from a lack of investor enthusiasm and are down by 19% despite the company beating top and bottom line estimates in its financial results for the first quarter. The loss per share during this period stood at $0.14 while revenue amounted to $17.7 million and represented an increase of 51.3% on a year-over-year basis. Point72 Asset Management held 267,400 shares of Novadaq Technologies Inc. (NASDAQ:NVDQ) at the end of March.

Follow Nevro Corp (NYSE:NVRO)
Trade (NYSE:NVRO) Now!

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.